• Construction of underground 786 BCF natural gas storage facility to be first in Mexico
• Engineering designs completed for bi-directional natural gas pipelines between Mexico and U.S.
• Overall demand for natural gas in Mexico expected to grow by 22 percent over next 15 years

Mirage Energy Corp. (OTC: MRGE), a natural gas storage and pipeline company based in Texas, intends to construct a first-of-its-kind massive underground natural gas storage facility with connecting bi-directional transmission pipelines in Mexico. The company has completed the engineering designs and schematics for the transmission pipelines that will run from various border locations in Texas to the company’s storage facility in Mexico. The company and its wholly owned subsidiaries are in the process of applying for and obtaining the necessary permits from the associated regulatory agencies in Mexico and the United States.

Mirage Energy Corp.’s underground natural gas storage facility will, for the first time, give Mexico the ability to balance peak loads by consumers, play price arbitrage on natural gas and create a Mexico Natural Gas hub for gas pricing and stability. The identified facility is a depleted natural gas reservoir with the ability to store 786 billion cubic feet (BCF) of natural gas. The first phase of the project includes construction of an initial storage field with capacity set to house 52 BCF of natural gas (http://dtn.fm/sE5Dp).

The project includes four 36-inch bi-directional transmission pipelines that vary in length from 27 miles to 95 miles, with two of the transmission lines boring underneath the Rio Grande. The pipelines, which are engineered to move 500 million cubic feet per day, will be used to inject natural gas into the company’s storage field and then to extract the fuel which can then be delivered to various customers in Mexico.

Recent reforms in Mexico’s electricity sector, intended to reduce government controls and create a more competitive market by opening it up to private investment, are expected to help the country build out its energy infrastructure and stabilize prices (http://dtn.fm/DN0Yk). Much of Mexico’s electricity is generated by natural gas-powered plants, and the bulk of that natural gas is imported from the United States, giving companies like Mirage Energy Corp. and their investors significant opportunities to benefit from the country’s booming natural gas market.

For more information, visit the company’s website at www.MirageEnergyCorp.com

• China will see nearly $2 trillion in new consumer-driven consumption by 2021
• Moxian facilitates Chinese consumer consumption
• Tweaked business model positions Moxian for more rapid expansion

China’s overall economic growth has slowed from its nearly 30 years of 10 percent annual improvement, but the Chinese consumer economy is still massive in absolute terms and poised for steadily increased expansion. With a population of 1.3 billion, China now comprises the world’s second-largest economy. Since the market reforms in 1978, China has shifted from a central government planned economy to a market-based economy and has experienced rapid consumer-driven economic development. China is now an upper middle-income country that sustains a targeted 6.5 percent GDP growth rate and has lifted nearly a billion people out of poverty. From centrally planned to consumer-driven, China’s growth is now consumer reliant.

China will see nearly $2 trillion in new consumer-driven consumption by 2021, which equates to about 27 percent of “total consumption growth” that will occur in the world’s major economies during the same period (http://dtn.fm/p4EEb). Over the next several years, China will prove to be one of the greatest opportunities in the world for consumer-oriented companies.

Technology is stoking China’s consumer growth. Skipping historic hard wired infrastructure, the Chinese consumer is mobile and internet savvy. About twice the percentage of Chinese consumers are likely to use a mobile device to make retail purchases as their counterparts in Europe and the United States.

Recently upgrading its mobile payments capability, Moxian, Inc. (NASDAQ: MOXC) is bridging e-commerce to brick and mortar retail. Moxian’s creative and socially interactive online platforms and mobile applications are moving the Chinese consumer from online views to retail purchases at Moxian’s brick and mortar client locations. The company’s seductive social network integrates social media and business into a single platform that offers products, features and services that appeal to consumers, keeping them engaged and referring new customers.

The company’s ingenious and captivating online platforms and mobile applications, the Moxian+ User app and the Moxian+ Business app, allow businesses to interface with both new and existing customers. These online interactions provide each business with the data to analyze consumer likes, dislikes and trends. Moxian’s platforms provide businesses with the ability to create, manage and promote individualized customer loyalty programs, targeted advertising campaigns and special promotions. These interactions between users and Moxian’s merchant clients drive retail traffic into the brick and mortar locations and give merchant client the ability to study consumer behavior and custom-tailor offerings to consumers.

To exploit the immense upside trend, Moxian recently tweaked its business model to grow even more rapidly by utilizing a joint venture strategy and leveraging entrenched businesses to efficiently penetrate China’s top four markets. MOXC’s relationship with China’s dominant payment processor, UnionPay, is integral to the new strategy. A UnionPay processing module on the Moxian+ platform allows MOXC to attract new joint venture partners in China and neighboring Asian markets. The Moxian+ Merchant platform now offers digital processing modules for UnionPay, Alipay, and WeChatPay. These modules allow payment processing as Moxian drives evermore traffic and engages evermore consumers. These changes place Moxian even more in the mix and poised to reap substantial rewards by facilitating the immense growth of the Chinese consumer market.

For more information, visit the company’s website at www.Moxian.com

• China is the second-largest global cosmetics consumer, representing $30 billion annually
• Savvy industry veteran recruited for vast untapped CBD skin care market
• 100% of cannabis skin care product market in China up for grabs

It comes as little surprise that cannabidiol (CBD) likely possesses skin healing properties. Found in the marijuana plant, CBD is one of over 80 natural compounds in marijuana that have been used for centuries as natural medicines and therapeutics. Cannabis is a known anti-inflammatory, containing antioxidants and anti-aging elements, while hemp seed oil contains both omega-3 and omega-6 fatty acids.

In spite of vast anecdotal evidence, science has not yet definitively settled on the positive effects of CBD skin care. However, the recent article “The Role of Cannabinoids in Dermatology,” published in the prestigious Journal of American Academy of Dermatology, suggests efficacy in CBD use for the treatment of several dermatologic conditions, including pruritus, inflammatory skin disease and skin cancer (http://dtn.fm/tQ6BS). It’s likely that even more beneficial effects will be found.

Further scientific validation will be icing on the cake for ChineseInvestors.com, Inc. (OTCQB: CIIX). With the introduction of its line of cannabidiol-based skin care products, CIIX is primed and fast moving into the multi-billion dollar Chinese skin care industry. The company has already filed a record of its first line of hemp-infused skin care products with the China Food and Drug Administration and expects to launch it in the next couple months. As the company stated in a recent press release, “Although ancient Chinese recognized the medicinal properties of the cannabis plant, CBD extract appears to be largely unrecognized in China today for its benefits, including but not limited to, its potential benefits to the largest visible human organ, the skin.”

China is the second-largest consumer of skin care products in the world and generates nearly $30 billion in annual retail sales. Since no other notable manufacturers have entered the cannabis skin care product market in China, CIIX would be first to market and anticipates capturing “100% of China’s market share in this novel skin care products category.” The market potential is immense.

To facilitate and expedite market dominance, CIIX recently appointed skin care industry veteran and Shanghai beauty influencer Fannie (Chun Fang) Tang as marketing director of its wholly-owned CBD Biotechnology Co., Ltd. enterprise. Well known in China, Tang will be responsible for developing and implementing branding strategies for the company’s CBD Magic Hemp Series skin care line (http://dtn.fm/ilH21).

Tang has proven success in the industry, bringing more than two decades of industry experience and previously serving as the CEO of L.D. Waxson, a leading skin care company with a footprint throughout China and much of Southeast Asia. Moving from CEO to director of marketing is a strong testament to the opportunity. There’s little doubt that with Tang’s experience, guidance and industry connections, CBD Biotechnology will position itself to become a leader in China’s skin care industry.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• STLHF adds 6,000 more acres to its Bristol Dry Lake Lithium Project, and aims to be a significant low-cost, domestic producer of battery-grade lithium materials
• Electric cars and smart phones use ion-lithium rechargeable batteries — driving prices and demand. According to Platt’s, lithium production can be expected to grow to 500,000 metric tons by 2020 from 200,000 today
• Goldman Sachs terms lithium “the new gasoline” as it projects that electric cars will have 61% market penetration by 2040, when it sees sales of electric cars outnumbering gasoline units

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is part of a worldwide race to produce enough lithium to satisfy the growing demand for the ore from electric car makers and smart phone makers. The question now is how soon miners can bring their lithium supply online to meet that demand. Companies such as Tesla have an insatiable demand for lithium, with Platt’s projecting that production could grow to 500,000 metric tons by 2020 from 200,000 today (http://dtn.fm/0wIWS).

STLHF is a junior lithium mining company with a market cap of only $62 million. Along with others, it is aggressively seeking to fill increased worldwide demand for lithium for the manufacture of lithium-ion batteries used in the manufacture of electric cars and smart phones. Goldman Sachs has termed lithium as “the new gasoline”, according to an article titled, “The Global Scramble For Lithium” (http://dtn.fm/Ze2yY). STLHF is focused on finding more lithium in the Bristol Dry Lake project to boost its valuation for investors as a significant low-cost, domestic producer of battery-grade lithium materials.

While Australia, Chile and China are top producers of lithium globally, according to Lithium Investing News (http://dtn.fm/5M5lO), STLHF has announced that its subsidiary, California Lithium Ltd., has signed an amendment agreement with National Chloride Company of America to expand its land production lease in California (http://dtn.fm/4SujJ). The U.S. is only the eighth-ranked lithium producer worldwide. According to the U.S. Geological Survey, “The U.S. has a lot more untapped lithium resources than economically mined reserves at this point” (Feb, 2017). Standard Lithium believes significant opportunity exists to develop geopolitically secure domestic U.S. lithium assets. The amended agreement adds 6,000 acres to STLHF’s land holdings in the Bristol Dry Lake Lithium Project, now totaling 25,000 acres in the Mojave region of San Bernardino County in California.

Lithium Investing News reports that lithium production rose 12% in 2016 to 35,000 metric tons. Morgan Stanley projects that more electric cars will be sold by 2040 than gas-powered cars, with market penetration growing from 16% in 2030 to 51% by 2040 (http://dtn.fm/w9RyQ). In its most bullish scenario, projections are that electric cars will reach 60% market penetration by 2040 and 90% by 2045. Whichever projection comes true, 159,000 more electric vehicles were on the road in 2016, and sales were up 38% over 2015 levels, according to research from FleetCarma (http://dtn.fm/aFHJ8).

For more information, visit the company’s website at www.StandardLithium.com

• Company has completed three profitable strategic acquisitions during 2017
• Revenue has increased 378-fold since first quarter 2017
• Ideally positioned to continue acquisition strategy and further grow revenues

In singling out success stories within the cannabis industry, SinglePoint, Inc. (OTC: SING) is a company that has definitely earned its place among the members of the marijuana market’s “Who’s Who.”

SinglePoint has been pursuing a diversified acquisition strategy within the cannabis industry this year with great success—something discussed in detail in a recently published article (http://dtn.fm/8wszX).

SinglePoint has evolved within a short time from having its core focus on advanced payment technologies and full-service mobile technologies, leveraging the its SingleSeed subsidiary to becoming a fully functioning holding company engaged in the acquisition of small- to mid-sized companies. Thus, SinglePoint has strategically established profitable footholds in the burgeoning cannabis market—all without touching the marijuana plant.

In late January 2017, SinglePoint announced the signing of a letter of intent to acquire an interest in Jacksam Corp., dba Convectium, closing the first round of funding for the acquisition in March. This acquisition marked the first in a successive—and ongoing—line of strategic investments intended to diversify SinglePoint’s revenue streams within the multibillion-dollar marijuana industry.

Convectium is a provider of equipment, branding and packaging solutions to the marijuana industry and the developer of the very first cartridge and vape pen oil-filling machines for wholesale distribution to cannabis dispensaries. The company’s 710Shark and 710Seal machines, sold through EquipCanna.com, are able to fill and package more than 100 cartridges or disposable vape pens in a mere 30 seconds. Additionally, Convectium operates B2C consumer brands that include BlackoutX and HazeSticks.

In May, SinglePoint acquired 90 percent of Discount Indoor Garden Supply (DIGS) in a stock and cash transaction, which immediately positioned SinglePoint as a leader in online products, retail stores, cannabis consulting and equipment in California. DIGS offers a broad array of growing equipment and accessories for individual and commercial plant cultivators, including growing supplies, hydroponic garden solutions, grow rooms and accessories, all-in-one units enabling private plant growth within the home, and more.

Teaming up with First Bitcoin Capital Corp. (OTC: BITCF), SinglePoint has additionally been engaged in developing a blockchain payments solution to enable cannabis enterprises to process debit and credit card payments using bitcoin—independent of federal sanction, which, at present, marijuana businesses in the United States do not have and, therefore, lack traditional banking options and have been forced to conduct transactions in cash.

Related to the development of its cryptocurrency payments solution, in August SinglePoint announced its purchase of $Weed from First Bitcoin Capital, which is a marijuana-specific cryptocurrency that recently had an initial coin offering launch that resulted in an impressive yet illiquid market cap of almost $60 million. $Weed currency is now being integrated into SinglePoint’s bitcoin payments solution.

On September 6, SinglePoint finalized its acquisition of profitable cannabis distribution company Dr. FeelGood, which offers a wide variety of products distributed through both B2B and B2C models.

It has, indeed, been a busy and profitable year for SinglePoint. As a result of its acquisition activity, the company’s revenue has increased 378-fold in contrast with its first quarter 2017 earnings, and SinglePoint is ideally positioned and well-capitalized to further its acquisition strategy and continue increasing its revenues going forward.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

• SWRM has been restructured for growth, projects $6-7 million revenues by 2018
• Total global mobile gaming expected to grow to $58.1 billion by 2018, estimated to show 15% YOY growth in 2017
• SuperDataResearch Report: In global dollars, mobile gaming is largest digital platform of interactive media revenue

AppSwarm, Inc. (OTC: SWRM) split into two divisions when it acquired MediaPlay in mid-August 2017, and the company is now positioned to take a bigger role internationally in the large and fast-growing global mobile gaming market.

Ron Brewer, CEO and director of the company, calls SWRM a high technology acceleration firm in the multi-platform games industry. It remains as one company after the restructuring, but it has two interactive divisions. The first is MediaPlay, a games publisher focused internationally on larger projects, such as supplying services to TV channels. The second is Incubation and Acquisition Development (IAD), which is charged with acquisitions, pursuing gaming opportunities and providing e-commerce business solutions to enhance SWRM’s organic and new growth.

Mobile gaming represents a $50.3 billion global market in 2017, and it is projected to reach $58.1 billion in 2018, according to the SuperDataResearch report “Trends and Insights On Games and Interactive Media 2017” (http://dtn.fm/Qa855). The report also found that 46% of the gamers in the U.S. are women, and the number of consumers who watch video game content online is roughly 665 million in 2017. The research firm estimates that more people will watch video gaming content in 2017 than those who watch HBO, Netflix, ESPN, and Hulu combined.

Brewer said in an interview (http://dtn.fm/LfM8z) that his management team projects sales of $6-7 million by FY2018. The company recently entered into a joint venture with Estorerunner, a nationally franchised “on-demand” delivery service for local grocery stores and pharmacies.

AppSwarm also recently announced that it is developing a proprietary “last-mile” delivery app platform “for management and implementation needs that create highly enhanced efficiencies” (http://dtn.fm/Y7Hyn).

For more information, visit the company’s website at www.App-Swarm.com

Let us hear your thoughts: AppSwarm, Inc. Message Board

• CIIX’s goal is 100% growth, cost cuts and profitability in FY2018 after recording 76% YOY operating sales jump in FY2017
• Valuation of CIIX “could explode with this huge potential market in China of 1.4 billion people,” according to investor relations director in SmallCapVoice interview
• Consilium Global Research projects CIIX sales will reach $14.8 million by FY2020

ChineseInvestors.com, Inc. (OTCQB: CIIX) is growing in numerous directions due to its diverse strategy of marketing, communications and product development both within China and to the global Chinese-speaking community. After recording YOY operating sales gains of 130% in investor relations and 57% in subscription revenue in FY2017, CEO Warren Wang said that the company’s goal is 100% more growth in FY2018 while cutting costs and achieving profitability. Overall, the company showed 76% YOY operating sales growth in FY2017. Diversity is the key to this skyrocketing growth (http://dtn.fm/e57MB).

Through its subsidiary, CBD Biotechnology Co. Ltd., CIIX is marketing, to the 1.4 billion people of China, its CBD-infused skin care line through multiple-channels, including retail, social media and direct marketing, Alan Klitenic, director of investor relations for CIIX, told SmallCapVoice.com in an interview (http://dtn.fm/DSL8n).

CIIX has a goal of becoming the primary Chinese publicly traded company in the medical cannabis industry. Its focus is on distributing legalized cannabidiol (CBD) to the worldwide Chinese-speaking community. Consilium Global Research projects that CIIX sales will reach $14.8 million by FY2020 (http://dtn.fm/2rzPY). The Hemp Business Journal estimates that the CBD market will reach $2.1 billion in consumer sales by FY2020, showing a compound annual growth rate (CAGR) of 80%, per Consilium Global Research.

Klitenic added that CIIX’s two divisions exhibited double- and triple-digit growth in FY2017. As it markets its line of hemp oil-infused skin care products, he said, the firm will target a large audience in China and the U.S. “We will also be selling through ecommerce on eBay and Amazon,” he said. “Our goal is to maximize revenues and shareholder value.”

He explained that by marketing the regulatory agency-approved CBD-infused skin care line in China, “Our valuation could explode with this huge potential market.” Klitenic said that the company is ready to make sales in China and spend dollars to be promotional and build its brand. Cannabis is known to have anti-inflammatory and antioxidant properties. The products have fatty acids in their hemp seed oil that improve skin complexion and maintain the skin’s moisture, according to company data.

Klitenic also noted that, this month, CIIX is planning to start broadcasting from the NYSE to its Chinese-speaking audience, offering information and video news about cryptocurrencies. “We are only an educational and news provider,” he said, aiming to answer the many questions it receives. “We recently acquired the domain name, newcoin168.com, to begin offering this video news service.”

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• Seeks patent on new therapy for drug that employs concentrations of THC
• Data for drug candidate IGC-AD1 finds that it reduces buildup of ‘senior plaque’ without causing death of neurons, which can lead to memory loss
• IGC plans to commercialize drug as a supplement to be marketed as a medical dispensary product

India Globalization Capital (NYSE MKT: IGC) recently announced that it is assembling a line of cannabis-based medical dispensary products targeting Alzheimer’s disease (http://dtn.fm/Rcl69). The company is engineering genetic cell lines which show that, at various concentrations of THC, the protein Aβ decreases as much as 40% without neuron damage.

This compelling in vitro data, and the promise it shows as a preventative and powerful treatment against Alzheimer’s, makes IGC a company with valuation growth potential for investors. The commercial potential for an Alzheimer’s treatment or prevention drug is in the billions of dollars. Investors have made Alzheimer’s drugs a high biotechnology priority.

IGC is a first-mover in the cannabis-based combination therapy space. The Bethesda, Maryland-based company has already filed for six patents in the markets of epilepsy, eating disorders and pain. It is also working on additional filings for indications including depression, Alzheimer’s disease, post-traumatic stress disorder and Parkinson’s disease.

“As Alzheimer’s progresses, synaptic dysfunction and the death of neurons lead to memory loss,” IGC CEO Ram Mukunda stated in a news release. “These study results, when combined with the earlier reported data that shows IGC-AD1 reduces Aβ40 and Aβ42 production by as much as 50% and 40%, without any toxicity, represent a highly significant novel breakthrough that could potentially bring much needed relief from this devastating disease.”

It is believed that a primary cause of Alzheimer’s disease is the buildup of senile plaque, or Aβ plaque, in the cerebral cortex and hippocampus. As the disease progresses, Aβ oligomers directly cause synaptic dysfunction and the death of neurons, leading to memory loss.

“In vitro, our product demonstrates these critical factors and we are pursuing a patent filing that protects this therapy,” Mukunda added.

IGC has a two-step plan. First, it will position IGC-AD1 both as a treatment and a preventative therapy for Alzheimer’s. Second, IGC plans to commercialize a supplement version of the drug to be sold as a medical dispensary product.

Alzheimer’s affects more than 5.3 million Americans, and more than 65% of the patients suffering from the disease are women. It is known as America’s most expensive disease, costing the economy an estimated $236 billion. Over the next 20 years, the number of people with the disease is expected to double. Alzheimer’s begins 20-25 years prior to clear symptoms. To date, no effective cure has been found.

For more information, visit the company’s website at www.IGCInc.us

• Price of zinc recently rose to $3,369 per metric ton, reaching highest point in more than a decade
• Estimated recovery rate of 95% for zinc seen at the Blue Moon site a key catalyst to its future development
• CEO Patrick McGrath calls the site “one of the best near-term development assets” in zinc mining

For Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF), the best may be yet to come. As zinc continues to rise in value, hovering near $3,369 per metric ton at time of writing (http://dtn.fm/N6uUg), the company is focused on its Blue Moon Project, located in Mariposa County, California. Zinc is used widely, largely in the manufacture of batteries and auto parts, but it has the future potential to be used in zinc-based batteries for electric cars and other energy storage applications.

Patrick McGrath, CEO, was originally just a shareholder of the junior zinc development company, but he said in a recent interview (http://dtn.fm/z8lKS) that he saw in Blue Moon, “one of the best near-term development assets” in zinc mining. He added that prior mid-tier mining companies had already done “most of the heavy lifting for us.” The project remained dormant after early work on the site for a number of reasons, most notably low zinc prices, but BMOOF estimates that there are some 377 million pounds of zinc indicated in the project and 395 million pounds inferred at the site, citing a recently completed mineral resource estimate (http://dtn.fm/IycK8).

Another reason other mining companies were reluctant to become involved in the site was California’s reputation for being “tough” in granting mining permits, but McGrath said that obtaining project permits within that state is no tougher than elsewhere, effectively “leveling the playing field.” A high estimated recovery rate of 95% for zinc at Blue Moon’s site is key to the company’s future development, McGrath said. The Blue Moon deposit is located on 525 acres in the foothills of the Sierra Nevada Mountains.

Although the market cap for the company is just $4.7 million, McGrath described BMOOF as being a great long-term investment for several reasons. One is its robust short-term “catalyst” in the next three months: its projected 1Q18 Preliminary Economic Assessment (PEA). The company said the PEA for the site would show its potential for economic development. The PEA, according to McGrath, should indicate Blue Moon as a viable stand-alone project. Next, the Blue Moon deposit is a volcanic massive sulphide (VMS) deposit, which are often found in ‘pods,’ indicating that more zinc deposits may be nearby.

McGrath said he sees a “high likelihood” that the Blue Moon project will offer an upside prospect for investors seeking exposure to zinc.

For more information, visit the company’s website at www.BlueMoonMining.com

Let us hear your thoughts: Blue Moon Zinc Corp. Message Board

• Technology improves absorption of cannabidiol and bioactive compounds into the bloodstream
• It is now being used on all non-psychoactive cannabinoids and applied to edibles and health food products
• Patents have been awarded in the U.S. and Australia and are pending in 44 countries

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds. Its patent-protected technology has improved the ability of cannabinoid-products companies to deliver active ingredients to the body. With patents pending for tetrahydrocannabinol and other psychoactive cannabinoids (plus nicotine and non-steroidal anti-inflammatory drugs), the current technology is already being applied to the use of non-psychoactive cannabinoids. This innovation has yielded a high absorption hemp oil formula that is a source of omega and fatty acids.

The health benefits of the technology and the products it has enabled are many. Lexaria has developed a product that can reduce anxiety and stress, increase mental focus and boost physiological performance and recovery. It can reduce pain and inflammation as well, while acting as a vasodilator to improve circulation.

Improved bioabsorption and lowering the cost of edibles are not the only perks of LXRP’s technology. The boost to the product market, and to investors, is already being felt. Avoiding the need for inhalation or co-administering CBD with sugars or sweeteners, the technology accelerates intestinal absorption. This has enabled the development of protein energy bars for sports nutrition and chewable CBD tablets with no sugar. Hemp oil capsules in the TurboCBD™ brand (with American ginseng and Ginkgo biloba) and teas have also been developed.

Lexaria’s technology works by masking the taste of cannabinoids as they’re consumed. It also protects the bioactive ingredients as they pass through the stomach and increases bioabsorption in the intestines by 5–10X. This rate is about equal to that of inhalation, offering a viable alternative to smoking. Onset times are also reduced. Effects may be felt with 15–20 minutes, in contrast to up to two hours via other means.

The patent awarded to LXRP for the delivery of all non-psychoactive cannabinoids makes Lexaria the first company in the world to achieve this accomplishment. Awarded in the U.S. and Australia, it is now pending in 44 other countries while supporting research and development on cannabinoids across the industry. The company has filed 19 patent applications in the U.S. and internationally. It also expects additional patent acceptances and issuances in 2017 and over the coming years.

In fact, Lexaria has out-licensed the technology as part of its royalty business model, allowing third-party partners and distributors to profit and support their own developments. The numerous deals already signed include those in various state markets, including California, Colorado and Nevada, and a distribution agreement for CBD chewables in Japan and South Korea. Lexaria’s first royalty agreement was with a fast-growing startup, but current negotiations are with larger, more established enterprises. Lexaria is expanding its global reach and expects to continue seeing growth in business deals in broader industry sectors with more well-known consumer brands.

For more information, visit the company’s website at www.LexariaEnergy.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board